12.26 USD
-0.13 (-1.05%)
12.26 USD
0 (0%)
OPRX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. OPRX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. OPRX is evaluated to be cheap and growing strongly. This does not happen too often!
1. Profitability
1.1 Basic Checks
In the past year OPRX was profitable.
OPRX had a positive operating cash flow in the past year.
In the past 5 years OPRX reported 4 times negative net income.
In multiple years OPRX reported negative operating cash flow during the last 5 years.
1.2 Ratios
OPRX's Return On Assets of 0.02% is fine compared to the rest of the industry. OPRX outperforms 74.29% of its industry peers.
The Return On Equity of OPRX (0.03%) is better than 74.29% of its industry peers.
OPRX has a Return On Invested Capital of 3.51%. This is in the better half of the industry: OPRX outperforms 68.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.02% | ||
| ROE | 0.03% | ||
| ROIC | 3.51% |
ROA(3y)-9.94%
ROA(5y)-6.64%
ROE(3y)-13.38%
ROE(5y)-8.85%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OPRX has a better Profit Margin (0.03%) than 74.29% of its industry peers.
OPRX's Operating Margin of 6.17% is fine compared to the rest of the industry. OPRX outperforms 71.43% of its industry peers.
OPRX has a Gross Margin (65.31%) which is in line with its industry peers.
In the last couple of years the Gross Margin of OPRX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.17% | ||
| PM (TTM) | 0.03% | ||
| GM | 65.31% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.49%
GM growth 5Y0.53%
2. Health
2.1 Basic Checks
OPRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
OPRX has more shares outstanding than it did 1 year ago.
OPRX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for OPRX has been reduced compared to a year ago.
2.2 Solvency
OPRX has an Altman-Z score of 3.20. This indicates that OPRX is financially healthy and has little risk of bankruptcy at the moment.
OPRX has a Altman-Z score of 3.20. This is in the better half of the industry: OPRX outperforms 71.43% of its industry peers.
OPRX has a debt to FCF ratio of 2.43. This is a good value and a sign of high solvency as OPRX would need 2.43 years to pay back of all of its debts.
OPRX's Debt to FCF ratio of 2.43 is fine compared to the rest of the industry. OPRX outperforms 71.43% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that OPRX is not too dependend on debt financing.
OPRX has a Debt to Equity ratio of 0.20. This is in the lower half of the industry: OPRX underperforms 60.00% of its industry peers.
Although OPRX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 2.43 | ||
| Altman-Z | 3.2 |
ROIC/WACC0.32
WACC11.02%
2.3 Liquidity
A Current Ratio of 3.05 indicates that OPRX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.05, OPRX is in line with its industry, outperforming 60.00% of the companies in the same industry.
OPRX has a Quick Ratio of 3.05. This indicates that OPRX is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.05, OPRX is doing good in the industry, outperforming 62.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.05 | ||
| Quick Ratio | 3.05 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 182.76% over the past year.
The Earnings Per Share has been growing by 101.23% on average over the past years. This is a very strong growth
Looking at the last year, OPRX shows a very strong growth in Revenue. The Revenue has grown by 24.18%.
The Revenue has been growing by 30.22% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)182.76%
EPS 3Y-9.14%
EPS 5Y101.23%
EPS Q2Q%66.67%
Revenue 1Y (TTM)24.18%
Revenue growth 3Y14.55%
Revenue growth 5Y30.22%
Sales Q2Q%22.33%
3.2 Future
OPRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 48.06% yearly.
Based on estimates for the next years, OPRX will show a quite strong growth in Revenue. The Revenue will grow by 13.83% on average per year.
EPS Next Y131.3%
EPS Next 2Y64.77%
EPS Next 3Y48.06%
EPS Next 5YN/A
Revenue Next Year19.98%
Revenue Next 2Y15.57%
Revenue Next 3Y13.83%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 14.95, the valuation of OPRX can be described as correct.
OPRX's Price/Earnings ratio is rather cheap when compared to the industry. OPRX is cheaper than 91.43% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.51. OPRX is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 13.68 indicates a correct valuation of OPRX.
85.71% of the companies in the same industry are more expensive than OPRX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, OPRX is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.95 | ||
| Fwd PE | 13.68 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, OPRX is valued a bit cheaper than the industry average as 68.57% of the companies are valued more expensively.
82.86% of the companies in the same industry are more expensive than OPRX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.75 | ||
| EV/EBITDA | 21.37 |
4.3 Compensation for Growth
OPRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OPRX's earnings are expected to grow with 48.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.11
PEG (5Y)0.15
EPS Next 2Y64.77%
EPS Next 3Y48.06%
5. Dividend
5.1 Amount
No dividends for OPRX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
12.26
-0.13 (-1.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners75.28%
Inst Owner Change5.13%
Ins Owners12.95%
Ins Owner Change1.22%
Market Cap228.53M
Revenue(TTM)109.51M
Net Income(TTM)32.00K
Analysts83.08
Price Target24.82 (102.45%)
Short Float %10.87%
Short Ratio6.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)807.75%
Min EPS beat(2)342.72%
Max EPS beat(2)1272.78%
EPS beat(4)4
Avg EPS beat(4)447.32%
Min EPS beat(4)8.43%
Max EPS beat(4)1272.78%
EPS beat(8)7
Avg EPS beat(8)250.62%
EPS beat(12)10
Avg EPS beat(12)191.95%
EPS beat(16)13
Avg EPS beat(16)147.27%
Revenue beat(2)2
Avg Revenue beat(2)17.89%
Min Revenue beat(2)7.23%
Max Revenue beat(2)28.56%
Revenue beat(4)4
Avg Revenue beat(4)13.8%
Min Revenue beat(4)4.37%
Max Revenue beat(4)28.56%
Revenue beat(8)6
Avg Revenue beat(8)4.84%
Revenue beat(12)8
Avg Revenue beat(12)2.3%
Revenue beat(16)8
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)28.07%
EPS NQ rev (1m)-6.85%
EPS NQ rev (3m)-28.53%
EPS NY rev (1m)12.81%
EPS NY rev (3m)12.81%
Revenue NQ rev (1m)-1.76%
Revenue NQ rev (3m)-4.36%
Revenue NY rev (1m)1.56%
Revenue NY rev (3m)1.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.95 | ||
| Fwd PE | 13.68 | ||
| P/S | 2.09 | ||
| P/FCF | 19.75 | ||
| P/OCF | 19.32 | ||
| P/B | 1.87 | ||
| P/tB | 25.51 | ||
| EV/EBITDA | 21.37 |
EPS(TTM)0.82
EY6.69%
EPS(NY)0.9
Fwd EY7.31%
FCF(TTM)0.62
FCFY5.06%
OCF(TTM)0.63
OCFY5.18%
SpS5.87
BVpS6.56
TBVpS0.48
PEG (NY)0.11
PEG (5Y)0.15
Graham Number11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.02% | ||
| ROE | 0.03% | ||
| ROCE | 4.45% | ||
| ROIC | 3.51% | ||
| ROICexc | 4.03% | ||
| ROICexgc | 28.04% | ||
| OM | 6.17% | ||
| PM (TTM) | 0.03% | ||
| GM | 65.31% | ||
| FCFM | 10.56% |
ROA(3y)-9.94%
ROA(5y)-6.64%
ROE(3y)-13.38%
ROE(5y)-8.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.49%
GM growth 5Y0.53%
F-Score7
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 2.43 | ||
| Debt/EBITDA | 2.24 | ||
| Cap/Depr | 5.95% | ||
| Cap/Sales | 0.24% | ||
| Interest Coverage | 1.25 | ||
| Cash Conversion | 106.61% | ||
| Profit Quality | 36153.1% | ||
| Current Ratio | 3.05 | ||
| Quick Ratio | 3.05 | ||
| Altman-Z | 3.2 |
F-Score7
WACC11.02%
ROIC/WACC0.32
Cap/Depr(3y)19.52%
Cap/Depr(5y)17.6%
Cap/Sales(3y)0.7%
Cap/Sales(5y)0.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)182.76%
EPS 3Y-9.14%
EPS 5Y101.23%
EPS Q2Q%66.67%
EPS Next Y131.3%
EPS Next 2Y64.77%
EPS Next 3Y48.06%
EPS Next 5YN/A
Revenue 1Y (TTM)24.18%
Revenue growth 3Y14.55%
Revenue growth 5Y30.22%
Sales Q2Q%22.33%
Revenue Next Year19.98%
Revenue Next 2Y15.57%
Revenue Next 3Y13.83%
Revenue Next 5YN/A
EBIT growth 1Y156.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year214.66%
EBIT Next 3Y53.84%
EBIT Next 5YN/A
FCF growth 1Y115790%
FCF growth 3Y154.28%
FCF growth 5YN/A
OCF growth 1Y549.84%
OCF growth 3Y88.49%
OCF growth 5YN/A
OPTIMIZERX CORP / OPRX FAQ
What is the ChartMill fundamental rating of OPTIMIZERX CORP (OPRX) stock?
ChartMill assigns a fundamental rating of 6 / 10 to OPRX.
Can you provide the valuation status for OPTIMIZERX CORP?
ChartMill assigns a valuation rating of 7 / 10 to OPTIMIZERX CORP (OPRX). This can be considered as Undervalued.
How profitable is OPTIMIZERX CORP (OPRX) stock?
OPTIMIZERX CORP (OPRX) has a profitability rating of 4 / 10.
How financially healthy is OPTIMIZERX CORP?
The financial health rating of OPTIMIZERX CORP (OPRX) is 7 / 10.
What is the earnings growth outlook for OPTIMIZERX CORP?
The Earnings per Share (EPS) of OPTIMIZERX CORP (OPRX) is expected to grow by 131.3% in the next year.